Form 4: Zoetis EVP Lagano Reports Routine Stock Transactions

Zoetis Inc. Executive Vice President Roxanne Lagano reported the acquisition of common stock through restricted stock unit vesting and subsequent tax-related dispositions.

Summary

• Roxanne Lagano, Executive Vice President of Zoetis Inc., reported changes in her beneficial ownership of common stock.
• On February 6, 2026, Lagano acquired 544 shares of common stock due to the vesting and settlement of restricted stock units (RSUs).
• Concurrently on February 6, 2026, she disposed of 217 shares at a price of $127.42 per share to cover tax withholding obligations.
• On February 8, 2026, Lagano acquired an additional 605 shares of common stock from RSU vesting and settlement.
• Also on February 8, 2026, she disposed of 221 shares at $127.42 per share for tax withholding.
• Following these transactions, Lagano directly owns 15,140 shares of Zoetis Inc. common stock.
• She also indirectly holds 833.684 common stock equivalents in the Zoetis Inc. Savings Plan (401(k)) as of December 31, 2025.
• The transactions involved the vesting of 544.7011 RSUs (granted February 6, 2024) and 605.7278 RSUs (granted February 8, 2023).
• These transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it reports routine, pre-scheduled executive compensation events that do not reflect discretionary trading or new information about the company's operational or financial performance.

Positives

• The vesting of restricted stock units indicates continued long-term incentive compensation for a key executive, aligning management interests with shareholder value.
• The transactions were pre-scheduled under a Rule 10b5-1(c) plan, suggesting routine compensation events rather than discretionary trading.

Negatives

• The disposition of shares for tax withholding purposes reduces the executive's direct ownership, which is a standard practice for RSU vesting.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance, focusing solely on past executive stock transactions.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vesting and tax-related sales, are common across publicly traded companies, particularly for executives whose compensation packages include equity awards. These types of filings generally do not indicate a change in company strategy or performance, but rather reflect standard executive compensation practices.

Comparison to Industry Standards

• StockSavvy.ai observes that the structure of executive equity compensation, involving restricted stock units that vest over several years, is a widely adopted practice among S&P 500 companies, including peers in the animal health sector like Elanco Animal Health (ELAN) and IDEXX Laboratories (IDXX).
• The disposition of shares to cover tax obligations upon vesting is also a standard and expected procedure, aligning with common industry practices for managing equity compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact, as these are routine executive compensation transactions. The continued equity ownership by an executive aligns their interests with shareholders.

Next Steps

• Future vesting of Restricted Stock Units granted on February 19, 2025, will occur on their first, second, and third anniversaries.

Key Dates

Recommendation

This Form 4 filing details routine, pre-scheduled executive stock transactions related to RSU vesting and tax withholding. It provides no new material information regarding Zoetis Inc.'s operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals and market conditions rather than this specific insider filing.

Keywords

Zoetis Inc., ZTS, Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, RSU Vesting, Executive Compensation, Roxanne Lagano, Stock Transaction, Rule 10b5-1